Defining “Innovativeness” in Drug Development: A Systematic Review
Authors:
- 30 May 2013
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 94 (3) , 336-348
Abstract
Some observers of drug development argue that the pace of pharmaceutical innovation is declining, but others deny that contention. This controversy may be due to different methods of defining and assessing innovation. We conducted a systematic review of the literature to develop a taxonomy of methods for measuring innovation in drug development. The 42 studies fell into four main categories: counts of new drugs approved, assessments of therapeutic value, economic outcomes, and patents issued. The definition determined whether a study found a positive or negative trend in innovative drug development. Of 21 studies that relied on counts, 9 (43%) concluded that the trend for drug discovery was favorable, 11 (52%) concluded that the trend was not favorable, and 1 reached no conclusion. By contrast, of 21 studies that used other measures of innovation, 0 concluded that the trend was favorable, 8 (47%) concluded that the trend was not favorable, and 13 reached no conclusion (P = 0.03).Keywords
This publication has 55 references indexed in Scilit:
- Innovative drugs and vaccines in China, India and BrazilNature Biotechnology, 2012
- Drug development: Innovation or imitation deficit?BMJ, 2012
- Using Market-Exclusivity Incentives to Promote Pharmaceutical InnovationNew England Journal of Medicine, 2010
- Introduction of European priority review vouchers to encourage development of new medicines for neglected diseasesThe Lancet, 2010
- US Pharmaceutical Innovation in an International ContextAmerican Journal of Public Health, 2010
- EVITA: a tool for the early EValuation of pharmaceutical Innovations with regard to Therapeutic AdvantageBMC Clinical Pharmacology, 2010
- Will biomedical innovation change the future of healthcare?Drug Discovery Today, 2009
- Developing a paradigm of drug innovation: an evaluation algorithmDrug Discovery Today, 2006
- Physicians’ Views Of The Relative Importance Of Thirty Medical InnovationsHealth Affairs, 2001
- Drug innovation—what's slowing it down?Nature, 1980